NLTX EV/EBITDA
N/A
Mon, 01 Jan 0001 00:00:00 GMT
Summary:
NLTX EV/EBITDA is not available.NLTX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NLTX EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| 6 m6 months | - |
| 1 y1 year | - |
| 5 y5 years | - |
NLTX EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | ||||
| 3 m | 3-month | ||||
| 6 m | 6-month | ||||
| 1 y | 1-year | ||||
| 3 y | 3-year | 1.30 | -0.67 | ||
| 5 y | 5-year | 1.30 | -18.52 | ||
| alltime | all time | 1.30 | -21.91 |
Neoleukin Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2023 | 0.19(+171.4%) |
| 2022 | 0.07(-105.4%) |
| 2021 | -1.29(-87.6%) |
| 2020 | -10.43(-27.4%) |
| 2019 | -14.36(-1830.1%) |
| Date | Value |
|---|---|
| 2018 | 0.83(-118.6%) |
| 2017 | -4.46(-53.4%) |
| 2016 | -9.58(+19.5%) |
| 2015 | -8.02(+188.5%) |
| 2014 | -2.78 |
FAQ
- What is the all time high EV/EBITDA for Neoleukin Therapeutics?
What is the all time high EV/EBITDA for Neoleukin Therapeutics?
Neoleukin Therapeutics all-time high EV/EBITDA is 1.30